This bad news for consumers as well as bad news for Eli Lilly and Amlyn Pharmaceuticals.
Recent studies have shown an increase of instances of thyroid cancer in rats treated with Byetta. It appears the drug may be following in the footsteps Novo Nordisk’s competing Victoza, which hold a similar warning. Granted, the Byetta dose given to rats in the study is 25 times the likely human dose. However, any time a drug increases a cancer risk (i.e., Actos) the risk-benefit analysis of the drug changes dramatically.
Byetta is also not new to safety challenges. Hundreds of lawsuits have already been filed alleging Byetta causes pancreatitis, renal failure, and pancreatic cancer.
I will be sure to keep on this emerging issue and post updates as they becoming available.
About the Firm: The Michael Brady Lynch Firm is a trial firm with a focus on pharmaceutical mass tort cases involving SSRI and Anti-Seizure Medication Birth Defects such as Lexapro, Zoloft, Effexor, Prozac, Celexa, Paxil, Depakote and Topamax, as well as Actos Bladder Cancer and Fosamax Femur Fractures, and medical device cases including DePuy Hip and Trans-Vaginal Mesh cases. Contact us today if you or someone you know has experienced side effects involving these products.
